secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytomX Therapeutics, Inc. (CTMX)
CIK:        0001501989
Form:       8-K
Filed at:   2022-03-23T23:59:59+00:00
Accession:  0001193125-22-082793
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Frederick W. Gluck to retire from CytomX board effective June 30, 2022
-------------------------------------------------------------------------------

- Frederick W. Gluck to retire from CytomX board effective June 30, 2022.
- Retirement not due to any dispute or disagreement with the company.
- No replacement named; board will be reduced by one member.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501989/000119312522082793/0001193125-22-082793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501989/000119312522082793/d340177d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-082793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer